Eyal Rubin

Eyal Rubin

Financieel Directeur/CFO bij NASUS PHARMA LTD.
49 jaar
Health Technology
Consumer Services
Commercial Services

Profiel

Eyal Rubin is Chief Financial Officer & Executive Vice President at Nasus Pharma Ltd. since 2025.
Former roles include CFO, Secretary, Treasurer & Senior Vice President at Protalix Biotherapeutics, Inc. from 2019 to 2025; Chief Financial Officer, Treasurer & Executive VP at Brainstorm Cell Therapeutics, Inc. from 2017 to 2019; Vice President & Head-Treasury at Teva Pharmaceutical Industries Ltd. from 2013 to 2017; Head-Finance & Banking Department at Cellcom Israel Ltd. from 2010 to 2013; Chief Financial Officer at Idt Carmel, Inc. from 2006 to 2010; Chief Financial Officer & General Manager at V-Secure Technologies, Inc. from 2003 to 2005; Chief Operating Officer & Vice President-Finance at Sec2Wireless, Inc. from 1999 to 2003.
Education includes an MBA from Bar-Ilan University and an undergraduate degree from The College of Management Academic Studies.

Actieve functies van Eyal Rubin

BedrijvenFunctieBegin
NASUS PHARMA LTD. Financieel Directeur/CFO 20-11-2025

Eerdere bekende functies van Eyal Rubin

BedrijvenFunctieEinde
PROTALIX BIOTHERAPEUTICS, INC. Financieel Directeur/CFO 24-08-2025
BRAINSTORM CELL THERAPEUTICS INC. Financieel Directeur/CFO 06-09-2019
TEVA PHARMACEUTICAL INDUSTRIES LIMITED Corporate Officer/Principal 01-01-2017
CELLCOM ISRAEL LTD. Corporate Officer/Principal 01-03-2013
Idt Carmel, Inc.
Financieel Directeur/CFO 01-01-2010
Ervaring van Eyal Rubin in detail bekijken

Opleiding van Eyal Rubin

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

67

Eerstegraads connecties

10

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit10

Health Technology

Health Technology

Commercial Services

Communications

Consumer Services

Electronic Technology

Health Technology

Consumer Services

Idt Carmel, Inc.

Health Technology

  1. Beurs
  2. Insiders
  3. Eyal Rubin